Publications by authors named "S Bezzeghoud"
Article Synopsis
- The effectiveness of oral anticoagulants in treating pulmonary arterial hypertension (PAH) is uncertain, with research showing mixed results regarding their safety and efficacy.
- In contrast, oral anticoagulants are essential for managing chronic thromboembolic pulmonary hypertension (CTEPH) and are recommended to prevent recurring blood clots.
- The selection of vitamin K antagonists versus direct oral anticoagulants involves weighing their pros and cons, especially considering drug interactions with other medications for PAH and CTEPH treatment.
Background: Interstitial lung disease (ILD) and pulmonary hypertension (PH) represent the major causes of mortality in systemic sclerosis (SSc). Patients with systemic sclerosis and combined PH and ILD (SSc-PH-ILD) generally have a poor prognosis. Predictors of survival and of potential benefit of treatment are lacking in patients with SSc-PH-ILD.
View Article and Find Full Text PDFBackground: The phenotype of patients seen for a suspicion of pulmonary hypertension has changed, with an increasing age and frequency of comorbidities. Selection of elderly patients, in whom a classical work-up is mandatory, is challenging. Comprehensive geriatric assessment (CGA) has modified the management of elderly patients with cancer.
View Article and Find Full Text PDF